Data support potential of innovative gene therapy using novel RNA editing, paired with targeted AAV.ai delivery and scalable ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene ...

A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...

This partnership marks an important milestone for Creyon as we work to advance our RNA-targeted oligo therapy pipeline to the clinic for both rare and common diseases,” said Serge Messerlian ...

STAAR Low-Grade Serous Ovarian Cancer Foundation and Not These Ovaries Fund Breakthrough Research at MD Anderson Cancer ...

The Boehringer Ingelheim Foundation is providing 600,000 Euros in funding for basic research into new approaches to the treatment of liver fibrosis and fatty liver hepatitis.

Eli Lilly and Creyon Bio have entered into a partnership worth over $1bn to develop RNA-targeted oligonucleotide (oligo) ...